Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: Absorption from various GI segments

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 24, Issue 6, 1996, Pages 551-568

  Lee, Sun H ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

Author keywords

Absorption from various segments of GI tract; Azosemide; Multiple peaks; Pharmacodynamics; Pharmacokinetics

Indexed keywords

AZOSEMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; DRUG URINE LEVEL; GASTROINTESTINAL TRACT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION; STOMACH EMPTYING;

ANIMALS; BILIARY TRACT; DIGESTIVE SYSTEM; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTESTINE, LARGE; INTESTINE, SMALL; MALE; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; SULFANILAMIDES;

EID: 0030434092     PISSN: 0090466X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02353480     Document Type: Article

References (32)

1. F. Krück, W. Bablok, E. Besenfelder, G. Betzien, and B. Kaufman. Clinical and pharmacological investigations of the new saluretic azosemide. Eur. J. Clin. Pharmacol. 14:153-161 (1978).
2. D. C. Brater, B. Day, S. A. Anderson, and R. Seiwell. Azosemide kinetics and dynamics. Clin. Pharmacol. Ther. 34:454-458 (1983).
3. D. C. Brater, S. A. Anderson, and S. Strowig. Azosemide, a "loop" diuretic, and furosemide. Clin. Pharmacol. Ther. 25:435-439 (1979).
4. B. Beerman and M. Grind. Clinical pharmacokinetics of some newer diuretics. Clin. Pharmacokin. 13:254-266 (1987).
5. S. H. Lee and M. G. Lee. Stability, tissue metabolism, tissue distribution and blood partition of azosemide. Biopharm. Drug Dispos. 16:547-561 (1995).
6. F. Kuzuya. Phase I study of azosemide (SK-110): single and multiple dose study. Int. J. Clin. Pharmacol. Ther. Toxicol. 21:10-23 (1983).
7. S. H. Lee, W. G. Shin, M. G. Lee, and N. D. Kim. Arterial and venous blood sampling in pharmacokinetic studies: Azosemide in rabbits. Biopharm. Drug Dispos. 15:305-316 (1994).
8. S. H. Lee, M. G. Lee, and N. D. Kim. Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: Absorption from various GI segments. J. Pharmacokin. Biopharm. 22:1-17 (1994).
9. S. H. Lee and M. G. Lee. Determination of azosemide and its metabolite in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 656:367-372 (1994).
10. T. Li, M. G. Lee, and W. L. Chiou. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide. J. Pharmacokin. Biopharm. 14:495-509 (1986).
11. W. H. Yoon, S. H. Lee, and M. G. Lee. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous bumetanide. J. Pharm. Sci. 84:236-242 (1995).
12. M. G. Lee and W. L. Chiou. Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism. J. Pharmacokin. Biopharm. 11:623-640 (1983).
13. F-H. Hsu, T. Prueksaritanont, M. G. Lee, and W. L. Chiou. The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: Extrapolation to human data based on the body surface area concept. J. Pharmacokin. Biopharm. 15:369-386 (1987).
14. M. Gibaldi and D. Perrier. Pharmacokinetics, Second Ed., Marcel Dekker, New York, 1982.
15. W. L. Chiou. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokin. Biopharm. 6:539-546 (1978).
16. S. H. Kim, Y. M. Choi, and M. G. Lee. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokin. Biopharm. 21:1-17 (1993).
17. W. L. Chiou. New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimen. J. Pharm. Sci. 68:1068-1069 (1979).
18. S. H. Lee and M. G. Lee. Factors influencing the protein binding of azosemide using an equilibrium dialysis technique. Biopharm. Drug Dispos. 16:615-626 (1995).
19. H. A. Ha, S. H. Lee, O. N. Kim, S. H. Kim, and M. G. Lee. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats. Res. Commun. Mol. Pathol. Pharmacol. 93: 109-128 (1996).
20. T. Asano, T. Inoue, and M. Kurono. Disposition of azosemide. I. Distribution, metabolism and excretion following intravenous administration to rats. Yakugaku Zasshi 104:1181-1190 (1984).
21. T. Inoue, M. Hayashi, A. Inoue, Y. Nakayama, Y. Hori, and M. Okada. Behavior of azosemide (SK-110) in the body - A study on ADME of azosemide in rats, rabbits, dogs and monkeys. Kiso to Rinsho (The Clinical Reports) 18:429-440 (1984).
22. L. L. Boles Ponto and R. D. Schoenwal. Furosemide (Frusemide). A pharmacokinetic/ pharmacodynamic review (Parts I and II). Clin. Pharmacokin. 18:381-408; 460-471 (1990).
23. L. L. Boles Ponto and R. D. Schoenwal. Furosemide (Frusemide). A pharmacokinetic/ pharmacodynamic review (Parts I and II). Clin. Pharmacokin. 18:381-408; 460-471 (1990).
24. B. Odlind, B. Beermann, and B. Lindström. Coupling between renal tubular secretion and effect of bumetanide. Clin. Pharmacol. Ther. 34:805-809 (1983).
25. M. G. Lee, T. Li, and W. L. Chiou. Effects of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm. Drug Dispos. 7:537-547 (1986).
26. G. Giebisch. In M. Martines-Maldonado (ed), Methods of Pharmacology, Vol. 4A, Plenum, New York, pp. 121-164, 1976.
27. V. S. Chungi, I. W. Dittert, and R. B. Smith. Gastrointestinal sites of furosemide absorption in rats. Int. J. Pharm. 4:27-38 (1979).
28. M. G. Lee, M.-L. Chen, and W. L. Chiou. Pharmacokinetics of drugs in blood II: Unusual distribution and storage effect of furosemide. Res. Commun. Chem. Pathol. Pharmacol. 34:17-23 (1981).
29. H. W. Chang, E. J. Yoon, M. G. Lee, and N. D. Kim. Pharmacokinetics of drugs in blood VI: Unusual distribution and storage effect of bumetanide. Seoul Univ. J. Pharm. Sci. 13:1-17 (1988).
30. Y. Suzuki, M. Ito, and T. Komura. Effects on diuresis, plasma renin activity, and urinary prostaglandin E excretion in normal rats. Folia Pharmacol. Japon 79:317-325 (1982).
31. M. Hayashi, K. Nakano, K. Asano, K. Takahashi, M. Takeda, M. Kurono, and Y. Suzuki. Pharmacological studies of azosemide (SK-110), a diuretic (1). Diuretic action in normal animals. Oyo Yakuri 28:819-835 (1984).
32. M. Hayashi, K. Nakuno, K. Mori, K. Niu, K. Mizuno, A. Yamamoto, M. Kouketsu, M. Kurono, and Y. Suzuki. Pharmacological studies of azosemide (SK-110), a diuretic (2). Diuretic action in rats with experimental model disease. Oyo Yakuri 28:837-849 (1984).